Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1995 Jul;58(1):4-10.
doi: 10.1006/gyno.1995.1175.

Long-term observation of patients treated by postoperative extended-field irradiation for nodal metastases from cervical carcinoma stages IB, IIA, and IIB

Affiliations
Review

Long-term observation of patients treated by postoperative extended-field irradiation for nodal metastases from cervical carcinoma stages IB, IIA, and IIB

T Inoue et al. Gynecol Oncol. 1995 Jul.

Abstract

Extended-field irradiation was administered to 72 patients after radical surgery for nodal metastases from cervical carcinomas at Stage IB (37 patients), IIA (6 patients), and IIB (29 patients) who were treated from 1981 to 1986. The 5-year disease-free survival rates (DFR) were significantly different between 61 squamous cell carcinomas and 11 nonsquamous cell carcinomas (72 versus 27%, P = 0.0051). In the 61 squamous patients, the DFR were 82% for 51 patients with resectable nodes and 20% for 10 patients with unresectable nodes (P = 0.0003). In the 51 patients with resectable nodes the DFR were 84% for Stage IB, 100% for Stage IIA, and 76% for Stage IIB. There were no significant differences among those categories subdivided by clinical stage, number of positive nodes, common iliac node metastasis, positive node laterality, depth of tumor invasion, parametrial extension, and menopause. These findings suggest that postoperative extended-field radiotherapy is effective in squamous cell carcinomas and that the prognostic values of these factors were decreased with high patients survival rates given by this combined therapy.

PubMed Disclaimer

Comment in

Similar articles

Cited by

MeSH terms